<DOC>
	<DOCNO>NCT00000377</DOCNO>
	<brief_summary>The purpose study compare effectiveness two dos nortriptyline elderly patient whose depression return stop treatment . Nortriptyline antidepressant . This study enroll patient treat depression earlier research study whose depression return since stopping treatment . Patients treat 4 month bring depression control . Patients assign randomly ( like toss coin ) receive either full dose nortriptyline half usual dose nortriptyline . Patients continue take nortriptyline 2 year major depression return . Throughout study , patient monitor symptom depression side effect .</brief_summary>
	<brief_title>Preventing Return Depression Elderly Patients</brief_title>
	<detailed_description>To determine whether elderly ( 60-80 year old ) depress patient sustain remission without medication must maintain full acute-treatment dose . To compare efficacy full-dose v half-dose nortriptyline ( NT ) prevent recurrence major depression elderly . To determine whether patient experience recurrence maintenance placebo condition ( Study I ) require 100 percent acute-treatment dose NT prevent subsequent recurrence successfully maintain 50 percent acute-treatment dose ( Study II ) . Investigators expect pool 60 patient Study I become eligible Study II ( full-dose/half-dose maintenance trial ) . After treatment recurrence follow 16 week stabilization therapy , patient randomize 1 2 maintenance therapy cell : full-dose NT half-dose NT . Maintenance last 2 year recurrence major depression . The follow assessed : difference recurrence rate time recurrence full-dose vs half-dose condition ; difference symptomatic rating depression , suicidal ideation , social adjustment , side effect ; difference compliance rate determine variability level-to-dose ( L/D ) ratio . Exploratory data analysis use generate hypothetical profile elderly patient remain well half-dose maintenance nortriptyline . For information relate study , please follow link : http : //clinicaltrials.gov/show/NCT00178100 http : //clinicaltrials.gov/show/NCT00177671</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<criteria>Patients must : Recurrence major depression maintenance placebo condition currently fund maintenance therapy protocol ( Study I ) .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Aged</keyword>
	<keyword>Antidepressive Agents</keyword>
	<keyword>Depression</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Female</keyword>
	<keyword>Human</keyword>
	<keyword>Male</keyword>
	<keyword>Middle Age</keyword>
	<keyword>Nortriptyline</keyword>
	<keyword>Placebos</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Aged , 80</keyword>
	<keyword>Antidepressive Agents -- *therapeutic use</keyword>
	<keyword>Antidepressive Agents -- administration &amp; dosage</keyword>
	<keyword>Depression -- *drug therapy</keyword>
	<keyword>Nortriptyline -- *therapeutic use</keyword>
	<keyword>Nortriptyline -- administration &amp; dosage</keyword>
</DOC>